Tucatinib Plus Trastuzumab and Capecitabine for ERBB2 (HER2)-Positive Metastatic Breast Cancer With Brain Metastases-Reply
- PMID: 37227737
- DOI: 10.1001/jamaoncol.2023.1391
Tucatinib Plus Trastuzumab and Capecitabine for ERBB2 (HER2)-Positive Metastatic Breast Cancer With Brain Metastases-Reply
Comment on
-
Tucatinib Plus Trastuzumab and Capecitabine for ERBB2 (HER2)-Positive Metastatic Breast Cancer With Brain Metastases.JAMA Oncol. 2023 Jul 1;9(7):1008-1009. doi: 10.1001/jamaoncol.2023.1388. JAMA Oncol. 2023. PMID: 37227708 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
